For nearly 30 years we have helped the world’s most innovative pharmaceutical and biopharmaceutical companies to navigate the challenges of new product development, drug delivery, production and market release. We provide a broad range of cGMP, GLP, GCP laboratory services, with a focus on support for the development and production of mRNA, oligos, peptides, biologics, or vaccines. We are adept in establishing GMP validated analytical methods including mRNA specific methods such as integrity, potency, capping efficiency, sequencing, Poly(A) Tail, residual DNA template, residual dsRNA and delivery system testing (e.g. lipid nanoparticles (LNPs)). These comprehensive characterisation services provide data to determine protein expression and product purity, which can be directly linked to translation efficiency and immunogenicity. We also provide ICH stability and formulation development programs and have leading expertise for inhaled and nasal drug product development.